ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,055Medicare Part D Prescriptions Filled, Including Refills
$620K Total Retail Price of All Prescriptions
601 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 473 378 S3
SIMVASTATIN 398 360
LISINOPRIL 398 367
LEVOTHYROXINE SODIUM 343 331
OMEPRAZOLE 320 275
AMLODIPINE BESYLATE 301 260
LOVASTATIN 220 194
CARVEDILOL 175 166
FUROSEMIDE 168 156
FINASTERIDE 166 153
HYDROCHLOROTHIAZIDE 157 142
WARFARIN SODIUM 153 137
LOSARTAN POTASSIUM 152 117
OXYCODONE HCL 148 91 S2
GABAPENTIN 140 110
TAMSULOSIN HCL 134 118
ATENOLOL 130 105
CLOPIDOGREL 129 112
POTASSIUM CHLORIDE 127 109
ZOLPIDEM TARTRATE 118 107
METFORMIN HCL 114 92
METOPROLOL TARTRATE 110 101
ATORVASTATIN CALCIUM 100 95
PLAVIX 96 91
MORPHINE SULFATE ER 95 57 S2
RANITIDINE HCL 92 82
VOLTAREN 90 84
SPIRIVA 88 75
METHADONE HCL 86 42 S2
ALLOPURINOL 82 75
SERTRALINE HCL 74 72
ALENDRONATE SODIUM 73 67
GEMFIBROZIL 68 53
GLYBURIDE 68 66 R
OXYCODONE HCL-ACETAMINOPHEN 66 50 S2
ADVAIR DISKUS 65 59
ZETIA 64 63
TRAZODONE HCL 61 54
AMITRIPTYLINE HCL 60 57 R
CLARITHROMYCIN 59 51
VENTOLIN HFA 59 40
CYCLOBENZAPRINE HCL 58 41 R
PEN NEEDLE 57 50
TRAMADOL HCL 56 41
NAMENDA 56 56
LOSARTAN-HYDROCHLOROTHIAZIDE 56 40
CIPROFLOXACIN HCL 53 48
HYDROMORPHONE HCL 53 41 S2
BENAZEPRIL HCL 53 48
PROBENECID 50 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.